Furthermore, the contribution of CAFs to the promotion of an immunosuppressive tumor environment remains to be investigated, as information on the mechanisms involved could be relevant to improve the anticancer efficiency of PD-L1/PD-1 immunotherapy. The gene discussed is CD274; the disease is neoplasm.